DJ AbbVie Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. $(ABBV)$ slid 1.15% to $214.98 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.72% to 6,575.32 and the Dow Jones Industrial Average rising 0.48% to 46,565.74.
The stock's fall snapped a two-day winning streak.
AbbVie Inc. closed 12.18% short of its 52-week high of $244.81, which the company reached on October 1st.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 0.13% to $244.12, Pfizer Inc. $(PFE)$ rose 1.67% to $28.55, and Amgen Inc. $(AMGN)$ rose 0.41% to $353.28.
Trading volume (5.6 M) remained 1.8 million below its 50-day average volume of 7.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled April 1, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 01, 2026 16:31 ET (20:31 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments